Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.

about

Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer.Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.

P2860

Q33599135-DDB7BA78-2D98-4A71-A270-A8AFA2C344FE Q38233149-28C1E397-E212-4F7A-B6FF-56814AB371CE

P2860

Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.

Item

http://www.wikidata.org/entity/Q36682422

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Temozolomide and/or Erlotinib ...... ral Nervous System Metastases.

@ast

Temozolomide and/or Erlotinib ...... ral Nervous System Metastases.

@en

type

Item

label

Temozolomide and/or Erlotinib ...... ral Nervous System Metastases.

@ast

Temozolomide and/or Erlotinib ...... ral Nervous System Metastases.

@en

prefLabel

Temozolomide and/or Erlotinib ...... ral Nervous System Metastases.

@ast

Temozolomide and/or Erlotinib ...... ral Nervous System Metastases.

@en

P1476

Temozolomide and/or Erlotinib ...... ral Nervous System Metastases.

@en

P2093

Martin Kelly Nicholas

http://www.w3.org/2001/XMLSchema#string

Philip C Hoffman

http://www.w3.org/2001/XMLSchema#string

Rimas V Lukas

http://www.w3.org/2001/XMLSchema#string

Victoria Villaflor

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Erlotinib in previously treated non-small-cell lung cancer

Brain metastases.

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

Comparison of single- and triple-dose contrast material in the MR screening of brain metastases.

Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.

Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4021/JNR85W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ravi Salgia

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236057194

http://www.w3.org/2001/XMLSchema#string

P698

23504695

http://www.w3.org/2001/XMLSchema#string

P932

3596833

http://www.w3.org/2001/XMLSchema#string

Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.

about

P2860

P2860

Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932